Waelkens E

No ORCID on file · 14 papers in corpus
article 2020
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-019-00081-w

A noninvasive diagnostic test for endometriosis is needed to shorten the current diagnostic delay of 8-11 years. The goal of this study was to discover new biomarkers for endometriosis using an antibody array approach. A total of 103 plasma…

article 2019
BioMed research international ·doi:10.1155/2019/3673060

There is a great need for a noninvasive diagnosis for endometriosis. Several biomarkers and biomarker panels have been proposed. Biomarker models consisting of CA-125, VEGF, Annexin V, and glycodelin/sICAM-1 were previously developed by our…

review 2018
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2018.04.001

A noninvasive biomarker-based test could help shorten the diagnostic delay for endometriosis. The most investigated biomarker sources are peripheral blood and endometrium. Discovery of endometriosis biomarkers is often hypothesis-driven, i.…

article 2017
Gynecologic and obstetric investigation ·doi:10.1159/000475664

Myeloperoxidase (MPO) is a proinflammatory enzyme and a marker for neutrophil activation and oxidative stress. Since oxidative stress and inflammation are linked to the pathogenesis of endometriosis, we hypothesized that the total, active, …

review 2016
Frontiers in bioscience (Landmark edition) ·doi:10.2741/4496

Multiplex immunoassays range from small-scaled multiplex sandwich ELISAs in a planar or bead-based format to the more expanded antibody arrays employing direct sample labeling. The plethora of data generated from these arrays could be of gr…

review 2013
Fertility and sterility ·doi:10.1016/j.fertnstert.2013.01.097

A noninvasive test for endometriosis would be useful for the early detection of endometriosis in symptomatic women who have pelvic pain and/or subfertility with normal ultrasound results. This would include nearly all cases of minimal-to-mi…

other 2013
Fertility and sterility ·doi:10.1016/j.fertnstert.2013.07.010
article 2012
Human Reproduction ·doi:10.1093/humrep/des127

BACKGROUND: An early semi-invasive diagnosis of endometriosis has the potential to allow early treatment and minimize disease progression but no such test is available at present. Our aim was to perform a combined mRNA microarray and proteo…

article 2012
Human Reproduction ·doi:10.1093/humrep/des234

BACKGROUND: At present, the only way to conclusively diagnose endometriosis is laparoscopic inspection, preferably with histological confirmation. This contributes to the delay in the diagnosis of endometriosis which is 6-11 years. So far n…

article 2012
Obstetrics and gynecology ·doi:10.1097/aog.0b013e31823fda8d

OBJECTIVE: To test the hypothesis that differential surface-enhanced laser desorption/ionization time-of-flight mass spectrometry protein or peptide expression in plasma can be used in infertile women with or without pelvic pain to predict …

article 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.06.034

This study indicates that the immunobiology of macroscopically normal peritoneum is relevant to understand the pathogenesis of endometriosis. Peritoneal interleukin 6, interleukin 12, and ferritin were differentially expressed in women with…

article 2010
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.06.084

ObjectiveTo test the hypothesis that specific proteins and peptides are expressed differentially in eutopic endometrium of women with and without endometriosis and at specific stages of the disease (minimal, mild, moderate, or severe) durin…

article 2010
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-8-123

BACKGROUND: According to mRNA microarray, proteomics and other studies, biological abnormalities of eutopic endometrium (EM) are involved in the pathogenesis of endometriosis, but the relationship between mRNA and protein expression in EM i…

article 2006
Fertility and sterility ·doi:10.1016/j.fertnstert.2005.12.024

ObjectiveTo test the feasibility of ProteinChip (Ciphergen Biosystems, Inc., Fremont, CA) technology as a proteomic tool in discovering and identifying proteins that are differentially expressed in endometrium, endometriotic tissue, and nor…